New And Special Drugs
-
Redemplo (Plozasiran) – FCS | HongKong DengYue Medicine
-
Yizekang (Izalontamab Brengitecan) – NPC/ESCC | HongKong DengYue Medicine
-
Qiyoukang (Gumokimab) – Plaque Psoriasis | HongKong DengYue Medicine
-
Lukeda (Rocbrutinib) – MCL | HongKong DengYue Medicine
-
Epkinly (Epcoritamab) – Follicular Lymphoma | HongKong DengYue Medicine
-
Blenrep (Belantamab Mafodotin) – Multiple Myeloma | HongKong DengYue Medicine
-
Hyrnuo (Sevabertinib) – NSCLC | HongKong DengYue Medicine
-
Foundayo(Orforglipron) – Obesity/Overweight | HongKong DengYue Medicine
What Can We Offer You?
Generic drugs
Dedicated to providing high-quality, affordable medicines around the world
Vitamins and Supplements
A balanced diet by addressing different deficiencies with the right dosage
brand name medicines
DengYue Medicine as China Drug Import and Export Wholesaler, fills the gap between quality and quantity by adding some affordability
Fast-moving consumer goods
Stock a full range of products from sanitary napkins to foot care creams for your daily needs
non-prescription drugs
Flagship OTC brand - approved and accepted by global standards
Medical supplies and auxiliary supplies
Explore continually updated supplies, diagnostic equipment and essential tools
News
HongKong DengYue Medicine Wholesaler focus on medical trends and obtain new drug directions.
Octahydroaminoacridine Succinate Approved in China for Alzheimer’s Disease, Marking Progress in Innovative Drug Development
On June 25, 2026, the National Medical Products Administration (NMPA) announced Octahydroaminoacridine Succinate approved in China for mild to moderate Alzheimer’s disease, marking another milestone
What Ovarian Cancer Drugs Are Available in China? Drug List and Clinical Uses
Ovarian cancer drugs in China mainly include five categories: PARP inhibitors, anti-angiogenic therapies, antibody-drug conjugates (ADCs), PD-1 immunotherapy, and chemotherapy, covering first-line treatment, maintenance therapy,
From First- to Third-Generation EGFR-targeted Drugs: How Can Patients Understand Differences in Efficacy and Adverse Effects?
Epidermal growth factor receptor EGFR–targeted drugs represent a cornerstone in the treatment of advanced non–small cell lung cancer (NSCLC) harboring EGFR gene mutations. EGFR mutations
Pharmaceutical Distributor in Hong Kong | Licensed Wholesale & Drug Export Partner
DengYueMed is a licensed Pharmaceutical Distributor in Hong Kong providing wholesale pharmaceuticals, global drug export, GDP-compliant distribution, and cold chain supply solutions for international markets.
What Are the Treatment Options for Duchenne Muscular Dystrophy? Current Therapies, Gene Therapy, and Emerging Treatments
What are the treatment options for Duchenne muscular dystrophy? Current treatment options for Duchenne muscular dystrophy include corticosteroids, exon-skipping therapies, gene therapy, rehabilitation, and supportive
China National Essential Medicines List 2026: Key Updates on Innovative Drugs, GLP-1 and Cancer Therapies
On July 9, 2026, China officially released the China National Essential Medicines List 2026, adding 116 medicines and bringing the total to 794. The updated
How to Find the Latest Breast Cancer Drugs: 7 Trusted Steps
How to find the latest breast cancer drugs begins with knowing your breast cancer subtype and using trusted sources such as official drug approvals, treatment
Top 5 Rare Disease Companies: An In-Depth Analysis of Roche, Novartis, Johnson & Johnson, AstraZeneca, and Vertex
The top 5 rare disease companies include Roche, Novartis, Johnson & Johnson, AstraZeneca, and Vertex Pharmaceuticals. These industry leaders are advancing orphan drugs, gene therapy,
Fast And Safe Delivery
Global Transportation Express
Temperature-controlled Transport
Safe Transportation, GDP Compliant
